Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1997-12-12
1999-12-28
Degen, Nancy
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 936, 4352351, 4353201, A01N 6300, C12N 1586, C12N 701, C12N 704
Patent
active
060078065
ABSTRACT:
The invention concerns a vector being vaccinia virus, which comprises a heterologous DNA sequence which codes at least for the essential region of a tumor specific protein called T antigen, cloned within a non essential region of the vaccinia virus, as well as regulatory element required for the expression of the DNA sequence in higher cells, the vector is particularly useful as a pharmaceutical composition having a preventive or creative activity against tumors especially tumors caused by a papillomavirus.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti
patent: 5744133 (1998-04-01), Lathe et al.
Rassoulzadegan et al., The roles of individual polyoma virus early proteins in oncogenic transformation, Nature, vol. 300, Dec. 23/30, 1982, pp. 713-718.
Tyndall et al., A region of the polyoma virus genome between the replication origin and late protein coding sequences is required in cis for both early gene expression and viral DNA replication, Nucleic Acids Research, vol. 9, No. 23, 1981, pp. 6231-6251.
Food and Drug Administration, HHS, 21 CFR Sections 620.1-620.33.
Treisman et al., Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein, Nature, vol. 292, Aug. 13, 1981, pp. 595-600.
Cason et al., Toward Vaccines Against Human Papillomavirus type-16 Genital Infections, Vaccine, vol. 11, 603-611, 1993.
Kieny Marie-Paule
Lathe Richard
Meneguzzi Guerrino
Degen Nancy
Transgene S.A.
LandOfFree
Expression of a tumor-specific antigen by a recombinant vector v does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression of a tumor-specific antigen by a recombinant vector v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of a tumor-specific antigen by a recombinant vector v will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2380429